Search - tctmd.com

Displaying 921 - 940 of 1718

Sort: Relevancy | Date

News Industry News

RE-DUAL PCI™ Results Offer Favorable New Safety Data on Pradaxa®

August 28, 2017

News Conference News ESC 2017

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

Shelley Wood

August 28, 2017

News Conference News ESC 2017

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

Shelley Wood

August 27, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Todd Neale

August 27, 2017

News Conference News ESC 2017

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Todd Neale

August 26, 2017

News Daily News

Iliac Artery Occlusions Best Addressed by Self-Expanding Stents: ICE Trial

Caitlin E. Cox

August 25, 2017

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

News Daily News

TAVR in the US: Regional Variations in Numbers, Outcomes

Michael O'Riordan

August 22, 2017

Studies Supporting Device Modifications Weak, Often Based on Surrogate Endpoints

News Daily News

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Michael O'Riordan

August 16, 2017

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Daily News

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

Michael O'Riordan

August 08, 2017

News Daily News

How SGLT2 Inhibitors Help the Heart: Biomarker Study Offers Clues

Leah Lawrence

August 01, 2017

News Daily News

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

Leah Lawrence

July 24, 2017

News Featured Fellow

Nirmanmoh Bhatia, MD

Yael L. Maxwell

July 11, 2017

News Conference News SCCT 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Yael L. Maxwell

July 10, 2017

News Daily News

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Michael O'Riordan

July 03, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

Shelley Wood

July 03, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

News Conference News EuroPCR 2017

More Early Stroke With SAVR Than TAVR in SURTAVI

Shelley Wood

May 18, 2017

Advertisement

RE-DUAL PCI™ Results Offer Favorable New Safety Data on Pradaxa®

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Iliac Artery Occlusions Best Addressed by Self-Expanding Stents: ICE Trial

Evolocumab Not Cost-Effective at Current List Price

TAVR in the US: Regional Variations in Numbers, Outcomes

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

How SGLT2 Inhibitors Help the Heart: Biomarker Study Offers Clues

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

Nirmanmoh Bhatia, MD

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

TCTMD’s Top 10 Most Popular Stories for June 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

More Early Stroke With SAVR Than TAVR in SURTAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content